Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Released Aug 14, 2026, after the close
10-Q filed Aug 14, 2026, 45 days after period end · 0001493152-26-038349
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $418.26K | $496.35K | $406.28K | $482.77K |
| Net Income | -$22.29K | $23.89K | -$10.04K | $68.41K |
| EPS Diluted |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
